Spotlight On: Biosimilar Litigations – October 2026

Start
Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference product sponsors as well as litigations between two biosimilar applicants/manufacturers are included. Litigations relating to disputes between two reference product sponsors, or non-practicing entities/universities and reference product sponsors are not included. Litigations related solely to manufacturing…
By: Venable LLP
Previous Story

Class Action & MDL Roundup | 2026 Q2 | This Case Is in the CATbird Seat

Next Story

What California’s New Lawyer AI Law Means for Litigants